The availability of global guidance for the promotion of women’s, newborns’, children’s and adolescents’ health and nutrition in conflicts

Abstract

BackgroundSignificant global gains in sexual, reproductive, maternal, newborn, child and adolescent health and nutrition (SRMNCAH&N) will be difficult unless conflict settings are adequately addressed. We aimed to determine the amount, scope and quality of publically available guidance documents, to characterise the process by which agencies develop their guidance and to identify gaps in guidance on SRMNCAH&N promotion in conflicts.MethodsWe identified guidance documents published between 2008 and 2018 through English-language Internet sites of humanitarian response organisations, reviewed them for their scope and assessed their quality with the AGREE II (Appraisal of Guidelines for REsearch and Evaluation II) tool. Additionally, we interviewed 22 key informants on guidance development, dissemination processes, perceived guidance gaps and applicability.FindingsWe identified 105 conflict-relevant guidance documents from 75 organisations. Of these, nine were specific to conflicts, others were applicable also to other humanitarian settings. Fifteen documents were technical normative guidelines, others were operational guides (67), descriptive documents (21) or advice on legal, human rights or ethics questions (2). Nutrition was the most addressed health topic, followed by communicable diseases and violence. The documents rated high quality in their ‘scope and purpose’ and ‘clarity of presentation’ and low for ‘rigour of development’ and ‘editorial independence’. Key informants reported end user need as the primary driver for guideline development and WHO technical guidelines as their main evidence base. Insufficient local contextualisation, lack of inter-agency coordination and lack of systematic implementation were considered problems in guideline development. Several guidance gaps were noted, including abortion care, newborn care, early child development, mental health, adolescent health beyond sexual and reproductive health and non-communicable diseases.InterpretationOrganisations are motivated and actively producing guidance for SRMNCAH&N promotion in humanitarian settings, but few documents address conflicts specifically and there are important guidance gaps. Improved inter-organisation collaboration for guidance on SRMNCAH&N promotion in conflicts and other humanitarian settings is needed.

Delivering nutrition interventions to women and children in conflict settings: a systematic review

“…This systematic review on nutritional interventions is a part of series of reviews in conflict settings which includes delivery of mental health, sexual and reproductive health and other interventions in conflict settings. [11][12][13][14][15][16][17][18] This review adheres to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement (online supplemental appendix 1), 19 and its protocol is registered with PROSPERO (the international prospective register of systematic reviews, www. crd.…”

Guidance on sexual, reproductive, maternal, newborn, child and adolescent health in humanitarian and fragile settings: a scoping review

“…To ensure vulnerable populations can be reached by essential health services, there is a need for guidance that is tailored to their needs and adapted to resource-strained settings. Existing guidance has seldom been contextualised to HFS and has been under-used when it comes to supporting evidence-based responses 17…”

Chemical and Biological Threats: Guidance for Breastfeeding Women, Infants, and Young Children

“…Despite the stark evidence of severe short- and long-term impacts of conflict on women and young children, this population has historically been overlooked when it comes to setting policy or providing holistic or human-centered guidance in conflict settings. 10 There are abundant guidelines and research available on chemical and biological threats and how the general population could be impacted, as well as references to the treatment of breastfeeding women when discussing antidotes, vaccines, and drug treatments. However, there is very little guidance on whether women can safely continue to breastfeed after specific chemical and biological events and at what point breastfeeding can be safely resumed.…”